María
Hernández Sánchez
María Hernández Sánchez-rekin lankidetzan egindako argitalpenak (10)
2022
-
TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914
2020
-
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792
-
Integrated genomic analysis of chromosomal alterations and mutations in B-cell acute lymphoblastic leukemia reveals distinct genetic profiles at relapse
Diagnostics, Vol. 10, Núm. 7
2019
-
CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
Leukemia, Vol. 33, Núm. 2, pp. 518-558
2017
-
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
Journal of Hematology and Oncology, Vol. 10, Núm. 1
2016
-
MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion
Leukemia Research, Vol. 46, pp. 30-36
-
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab
British journal of haematology, Vol. 172, Núm. 3, pp. 428-438
2015
-
MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL
BMC Cancer, Vol. 15, Núm. 1
2014
-
Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia
BioMed Research International, Vol. 2014